Theratechnologies Inc. (THTX) Financials

THTX Assets vs Liabilities

DateAssetsLiabilities
May 31, 2025 51.3 million 79.2 million
Feb. 28, 2025 56.5 million 80.9 million
Nov. 30, 2024 53.3 million 78.6 million
Aug. 31, 2024 69.7 million 89.4 million

THTX Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
May 31, 2025 12.4 million 978000
Feb. 28, 2025 -19.8 million 648000
Nov. 30, 2024 -227000 2.2 million
Aug. 31, 2024 4.6 million 387000

THTX Net Income

No data available :(

THTX Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
May 31, 2025 9.9 million 40.0 million 886000
Feb. 28, 2025 4.3 million 45.7 million 873000
Nov. 30, 2024 9.6 million 41.7 million 1.2 million
Aug. 31, 2024 38.9 million 36.5 million 689000

THTX Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
May 31, 2025 49.4 million
Feb. 28, 2025 50.4 million
Nov. 30, 2024 49.4 million
Aug. 31, 2024 49.4 million

THTX Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
May 31, 2025 8000 2.6 million 12.3 million 6.8 million
Feb. 28, 2025 10.1 million 3.0 million 10.7 million 6.5 million
Nov. 30, 2024 - 5.9 million 12.1 million 7.0 million
Aug. 31, 2024 - 2.6 million 9.3 million 6.3 million

THTX Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
May 31, 2025 17.7 million 4.7 million
Feb. 28, 2025 19.0 million 3.5 million
Nov. 30, 2024 25.0 million 6.1 million
Aug. 31, 2024 22.6 million 4.5 million

THTX

Price: $3.39

52 week price:
1.12
3.40

Earnings Per Share: -0.19 USD

P/E Ratio: -17.84

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: Canada

Volume: 5200

Market Capitalization: 155.9 million

Links: